Psilocybin for the Treatment of Obsessive-Compulsive Disorders.
Katja Ehrmann, John J B Allen, Francisco Moreno
Current Topics in Behavioral Neurosciences January 1, 2022 DOI: 10.1007/7854_2021_279 (opens in new tab) via PubMed
Summary
AI-generated from the abstractObsessive-compulsive disorder (OCD) is a common and disabling condition for which current treatments are often insufficient, making alternative approaches a priority. Psilocybin may offer a safe and effective treatment avenue. This chapter reviews OCD symptoms, epidemiology, and disease mechanisms, along with existing treatments and their limitations, as background for discussing psilocybin and similar compounds. It covers psilocybin's mechanisms of action relevant to OCD and describes the authors' experiences with incidental observations, prospective research, and ongoing explorations of psilocybin for OCD.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | Psilocybin |
| Topics | Psilocybin |
| Keywords | Compulsions OCD Obsessions Obsessive-compulsive disorder |
| Key finding | Psilocybin may represent a safe and effective treatment for OCD, but further research is needed. |
Abstract
Obsessive-compulsive disorder (OCD) is a highly prevalent and disabling condition for which currently available treatments are insufficiently effective and alternatives merit priority attention. Psilocybin may represent a safe and effective avenue for treatment of individuals affected by this condition. In this chapter we briefly introduce OCD symptoms, epidemiology, as well as relevant hypotheses on the mechanism of disease that may inform treatment interventions. We briefly describe currently available treatments, mechanisms of action, and efficacy limitations, as preamble to the potential use of psilocybin and perhaps similar compounds in the treatment of OCD and related conditions. Although much is reviewed throughout this book about the mechanisms of action of psychedelic agents, a focused discussion of psilocybin effects as they pertain to OCD is also included. Our experience with incidental observation, prospective research, and current explorations of psilocybin in OCD are also described.